share_log

HC Wainwright & Co. Initiates Coverage On NextCure With Buy Rating, Announces Price Target of $7

HC Wainwright & Co. Initiates Coverage On NextCure With Buy Rating, Announces Price Target of $7

HC Wainwright & Co.以買入評級啓動NextCure的保險,宣佈目標股價爲7美元
Benzinga ·  2023/08/08 06:11

HC Wainwright & Co. analyst Emily Bodnar initiates coverage on NextCure (NASDAQ:NXTC) with a Buy rating and announces Price Target of $7.

HC Wainwright & Co. 分析師艾米麗·博德納爾開始對NextCure(納斯達克股票代碼:NXTC)進行報道,評級爲買入,並宣佈目標股價爲7美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論